Should I increase aripiprazole (Abilify) or lamotrigine?

The Decision: Increase Lamotrigine, Not Aripiprazole

Without knowing your specific diagnosis, I cannot make a definitive recommendation, but the FDA drug label explicitly states that no dosage adjustment is necessary for lamotrigine when coadministered with Abilify (aripiprazole), indicating these medications can be safely used together at their current doses 1. The critical question is: what are you treating?

If You Have Bipolar Disorder

For Bipolar Depression

Increase lamotrigine first. Lamotrigine is a first-line treatment for bipolar I depression and maintenance therapy 2, 3. It has strong evidence for preventing depressive episodes without triggering mania in most patients.

• Start with lamotrigine titration to therapeutic doses (typically 200 mg/day)
• Aripiprazole is first-line for acute mania but NOT for bipolar depression 3
• Critical warning: Lamotrigine can induce mania in vulnerable populations—specifically those with bipolar I disorder, manic predominant polarity, or history of antidepressant-induced switches 4. If you have these risk factors, use extreme caution with lamotrigine increases.

For Bipolar Mania or Mixed Episodes

Increase aripiprazole first. Aripiprazole is a first-line treatment for acute mania in bipolar I disorder 2, 3, 5. Lamotrigine has NO antimanic effects and could worsen manic symptoms 4.

For Maintenance/Prevention

Both medications are first-line for maintenance in bipolar I disorder 3. The hierarchy depends on your predominant polarity:

• Depressive predominance: Prioritize lamotrigine
• Manic predominance: Prioritize aripiprazole
• Mixed/unclear: Consider augmentation rather than increasing either alone 6

If You Have Major Depressive Disorder (Treatment-Resistant)

Increase aripiprazole, not lamotrigine. For treatment-resistant depression, aripiprazole augmentation has demonstrated efficacy 7, 8. However, recent risk-benefit analysis shows important caveats:

• If you are overweight (BMI ≥25): Aripiprazole augmentation may cause net harm due to metabolic effects and tardive dyskinesia risk, resulting in -22.8 depression-free day-equivalents 8
• If you are normal weight and under age 85: Aripiprazole offers modest benefit (8.0 depression-free day-equivalents) 8
• Lamotrigine is NOT indicated for unipolar depression

Critical Safety Concerns When Using Both Together

Akathisia and Suicidal Ideation Risk

The combination of aripiprazole and lamotrigine can cause severe akathisia, increased anxiety, and suicidal thoughts 9. This is a serious, potentially life-threatening adverse effect.

• Start aripiprazole at LOW doses when combined with lamotrigine
• Monitor closely for restlessness, inner tension, inability to sit still
• If akathisia develops, discontinue aripiprazole immediately 9

Metabolic Effects

Over 52 weeks, aripiprazole added to lamotrigine caused modest weight gain (+0.4 kg), while lamotrigine alone caused weight loss (-2.2 kg) 10. If metabolic health is a concern, this favors lamotrigine optimization.

Drug Interactions

The FDA label confirms no pharmacokinetic interaction requiring dose adjustment 1. However, pharmacodynamic interactions (the combined effects on your brain) are significant 9.

The Algorithm for Decision-Making

Step 1: Confirm your diagnosis

• Bipolar I disorder → Follow bipolar algorithm above
• Bipolar II disorder → Similar to bipolar I but with less mania risk
• Major depressive disorder → Aripiprazole augmentation (if normal weight)

Step 2: Identify current symptom target

• Active depression → Lamotrigine (bipolar) or aripiprazole (unipolar)
• Active mania → Aripiprazole only
• Maintenance/prevention → Based on predominant polarity

Step 3: Assess risk factors

• Overweight/obese → Avoid increasing aripiprazole 8
• History of manic switches → Use extreme caution with lamotrigine 4
• Age >85 years → Consider fall risk with either medication

Step 4: Monitor for combination toxicity

• Weekly assessment for akathisia symptoms for first month after any dose change
• Immediate discontinuation if severe restlessness or suicidal thoughts emerge 9

Common Pitfalls to Avoid

1. Don't increase lamotrigine during active mania—it lacks antimanic properties and may worsen symptoms through its antidepressant effects 4

2. Don't assume aripiprazole is safe for everyone with depression—in overweight patients with treatment-resistant depression, the metabolic harms outweigh benefits 8

3. Don't ignore akathisia symptoms—this combination carries specific risk for severe, treatment-limiting akathisia that can precipitate suicidal ideation 9

4. Don't increase both simultaneously—this makes it impossible to determine which medication is helping or causing side effects